CCTN - 女性网站 - 长效可逆避孕药的评估-猫眼课题宝

CCTN - 女性网站 - 长效可逆避孕药的评估

批准号：

9152426

负责人：

KATHARINE WHITE

金额：

$33.78万

依托单位：

BOSTON MEDICAL CENTER

依托单位国家：

美国

项目类别：

财政年份：

2015

资助国家：

美国

项目状态：

已结题

起止时间：

2015-09-25 至 2018-09-24

来源：

https://reporter.nih.gov/project-details/9152426

关键词：

Adverse effects Age Attitude Child Child health care Chlamydia Clinical Practice Guideline Clinical Trials Network Contraceptive Agents Contraceptive History Contraceptive methods Copper Intrauterine Devices Counseling Data Data Analyses Development Devices Eligibility Determination Enrollment Evaluation Excision Female Future Gonorrhea Good Clinical Practice Guidelines Hemorrhage Hormones Human Development Incidence Informed Consent Institutes International Intrauterine Devices Lead Medical Menstrual cycle Methods Muscle Cramp National Institute of Child Health and Human Development Pain Pap smear Pattern Phase Pregnancy Pregnancy Tests Preparation Procedures Protocols documentation Randomized Randomized Controlled Clinical Trials Recording of previous events Records Recovery Recruitment Activity Regulation Reproductive History Risk Risk Factors Safety Sampling Site Specific qualifier value Testing Thromboembolism Ultrasonography Urine Venous Visit Woman Writing arm birth control contraceptive effectiveness contraceptive efficacy demographics effectiveness trial follow-up medically necessary care novel prospective protocol development reproductive screening standard of care symposium trial design

项目摘要

项目成果

KATHARINE WHITE的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

To evaluate contraceptive efficacy, pain of insertion, bleeding patterns, associate cramping, expulsion rates as well as other safety and side effects of the long acting reversible contraceptive (LARCs) in women of reproductive age. The Contraceptive Discovery and Development Branch (CDDB) under the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is committed to develop new methods that are long acting reversible contraceptives that can provide safe and effective contraception for women who may have risk factors against some contraceptive products as well as reduce the risk of venous thromboembolism (VTE). The copper intrauterine devices (IUDs) are example of intrauterine systems that provide long acting contraceptive benefits without exogenous hormones or disruption of the regular menstrual cycle.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文